🇺🇸 Abitren in United States
14 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 14
Most-reported reactions
- Blood Creatinine Increased — 3 reports (21.43%)
- Malaise — 2 reports (14.29%)
- Renal Impairment — 2 reports (14.29%)
- Acute Kidney Injury — 1 report (7.14%)
- Adverse Event — 1 report (7.14%)
- Aphonia — 1 report (7.14%)
- Assisted Fertilisation — 1 report (7.14%)
- Back Pain — 1 report (7.14%)
- Blood Pressure Fluctuation — 1 report (7.14%)
- Cardiac Failure — 1 report (7.14%)
Other Other approved in United States
Frequently asked questions
Is Abitren approved in United States?
Abitren does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Abitren in United States?
Carmel Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.